Last reviewed · How we verify
Remifemin Preventing the Climacteric Symptoms in Breast Cancer
LHRH-a is an important hormone treatment in breast cancer especially in high-risk hormone receptor-positive patients or hormone receptor-negative but needing ovarian function protecting. The climacteric symptoms caused by LHRH-a are often and prominent, which is a common clinical problem.
Details
| Lead sponsor | Zhejiang Cancer Hospital |
|---|---|
| Phase | PHASE2 |
| Status | COMPLETED |
| Enrolment | 85 |
| Start date | Wed Jan 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Effect of Drugs
- Safety Issues
Interventions
- Remifemin
Countries
China